Clinical Trials on Hypertrophy Breast in Japan
Total 247 results
-
Bristol-Myers SquibbRecruitingHypertrophic CardiomyopathyJapan
-
Nagoya UniversityUnknownHypertensive Left Ventricular HypertrophyJapan
-
Bristol-Myers SquibbActive, not recruitingCardiomyopathy, Hypertrophic ObstructiveJapan
-
Hiroaki Shimokawa, MD, PhDUnknownHeart Failure | Coronary Disease | Heart Valve Diseases | Cardiomyopathies | Left Ventricular HypertrophyJapan
-
Bristol-Myers SquibbActive, not recruitingCardiomyopathy, HypertrophicSpain, Austria, Belgium, Brazil, Canada, Denmark, France, Germany, Hungary, Israel, Japan, Netherlands, Norway, Poland, Portugal, United Kingdom, United States, Australia, China, Czechia, India, Italy, Korea, Republic of
-
TakedaCompletedPremenopausal Breast CancerJapan
-
Astellas Pharma IncCompletedOveractive Bladder | Benign Prostatic Hyperplasia | Benign Prostatic HypertrophyJapan
-
AgendiaOsaka General Medical CenterCompleted
-
Japanese Foundation for Cancer ResearchChugai PharmaceuticalActive, not recruiting
-
Kyoto Breast Cancer Research NetworkCompleted
-
Osaka Medical CollegeCompletedBreast Cancer | Effects of Chemotherapy | HER-2 Positive Breast CancerJapan
-
Comprehensive Support Project for Oncology ResearchCompleted
-
Tokyo Medical UniversityTokyo University; Saint Luca International HospitalCompleted
-
Kyoto Prefectural University of MedicineActive, not recruiting
-
Okayama UniversityMerck Sharp & Dohme LLCRecruitingBreast Cancer | Breast Neoplasms | Triple Negative Breast Cancer | Triple Negative Breast Neoplasms | BRCA1 Mutation | BRCA2 Mutation | BRCA Mutation | BRCA-Associated Breast CarcinomaJapan
-
Kyoto Breast Cancer Research NetworkTerminated
-
Tokyo Medical and Dental UniversityRecruitingBreast Cancer | Metastatic Breast Cancer | OligometastasisJapan
-
Nippon Kayaku Co., Ltd.CompletedBreast Cancer Nos Metastatic RecurrentJapan
-
GlaxoSmithKlineCompleted
-
Osaka Medical CollegeTerminatedBreast Cancer | HER-2 Positive Breast Cancer | Estrogen Receptor Negative NeoplasmJapan
-
AstraZenecaCompletedNeoplasms | Breast Cancer | Metastatic CancerJapan
-
Astellas Pharma IncAstellas Pharma Singapore Pte. Ltd.Completed
-
Tokyo UniversityHuman Genome Center, Institute of Medical Science, University of TokyoTerminated
-
Eli Lilly and CompanyCompletedBreast Cancer | Metastatic Breast CancerJapan
-
National Cancer Center, JapanH.U. Group Research Institute G.K.RecruitingHER2-positive Breast CancerJapan
-
Tokyo UniversityHuman Genome Center, Institute of Medical Science, University of TokyoTerminated
-
Eisai Co., Ltd.CompletedBreast Cancer | HER2-negative Breast CancerJapan
-
AstraZenecaActive, not recruitingER+ HER2- Advanced Breast CancerJapan
-
Chugai PharmaceuticalCompleted
-
Japan Breast Cancer Research GroupChugai PharmaceuticalCompletedMetastatic Breast CancerJapan
-
AstraZenecaCompleted
-
AstraZenecaCompleted
-
Comprehensive Support Project for Oncology ResearchNovartis PharmaceuticalsCompleted
-
GlaxoSmithKlineCompletedNeoplasms, BreastJapan
-
GlaxoSmithKlineCompleted
-
Taiho Pharmaceutical Co., Ltd.Completed
-
Eisai Co., Ltd.Completed
-
National Cancer Institute (NCI)CompletedHER2-positive Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast CancerUnited States, Japan
-
Eisai Co., Ltd.Active, not recruiting
-
Translational Research Center for Medical Innovation...Department of breast and endocrine surgery graduate school of Medicine Osaka...Terminated
-
Institut de Recherches Internationales ServierADIR, a Servier Group companyCompletedMetastatic Breast Cancer | Metastatic Triple Negative Breast CancerJapan, Belgium, France, Netherlands
-
Taiho Pharmaceutical Co., Ltd.Completed
-
GlaxoSmithKlineCompletedMetastatic Breast Cancer | Neoplasms, BreastJapan
-
Anwar Ali Ahmad AlameerCompletedEffect of Health Education Regarding Screening Tools of Breast CancerSaudi Arabia
-
Kyowa Kirin Co., Ltd.Completed
-
Translational Research Center for Medical Innovation...Completed
-
GlaxoSmithKlineCompleted
-
Eisai Co., Ltd.Completed
-
M.D. Anderson Cancer CenterTerminatedBreast CancerUnited States, Japan